Navis Bio

Clinical AI that finds what's hidden

Küsnacht, Zurich, Switzerland

Navis Bio is an AI-powered biopharma intelligence company providing agentic AI solutions for translational medicine. It uses agentic AI to extract insights from scientific literature, clinical trials, and drug development data, and provides custom business process automation for biopharma organizations.

Shareable draft

Check out Navis Bio on @MedStartr Today Navis Bio is an AI-powered biopharma intelligence company providing agentic AI solutions for translational medicine. It uses agentic AI to extract insights from scientific literature, clinical trials, and drug development data, and provides custom business process automation for biopharma organizations. #MentalBehavioralHealth #DrugDiscoveryDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/kY0BEe7nalA

Get Involved in Navis Bio

How We Help

Problem Statement

Navis Bio enables biopharma organizations to make better, data-driven decisions for drug discovery and development by extracting non-obvious insights from scientific literature, clinical trials, and drug development data.

Core Technology

Agentic AI

Key Differentiators

Uses agentic AI for autonomous task execution rather than passive assistance; Occupies a distinct niche in translational research data integration and intelligence rather than de novo drug discovery; Developed open-source AI tools for translational research and biomedical data analysis; Enables direct querying of clinical trial data with natural language interfaces

Clinical Focus

translational medicine; clinical trials

Company Info

Business Model: B2B SaaS
Founded: 2024

Disease Areas

Mental Health

Technologies

Agentic AIAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Integrates with CTTI's AACT database; Founded 2024; DayOne Accelerator 2025 cohort; SOC2 certified

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Navis Bio?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.